Skip to content

Welcome to Discover Pharma! Today is : October 11, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

CAR-T

  • Advanced Therapies,Central Nervous System,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    Laverock Therapeutics expands into in vivo CAR-T and genetic medicine

    Laverock Therapeutics is expanding its therapeutic pipeline into in vivo [...]

    September 30, 2026
  • Advanced Therapies,Drug Delivery & Formulation,Drug Discovery & Development,Research & Development

    Circio and Full Circles Therapeutics combine technologies for in vivo cell therapy

    Circio and Full Circles Therapeutics are combining circular RNA and [...]

    August 27, 2026
  • Digital & Data,Drug Discovery & Development,Research & Development

    Latent Labs opens lab-validated AI drug design platform to researchers worldwide

    Latent Labs has launched its artificial intelligence-powered drug design platform [...]

    July 15, 2026
  • Advanced Therapies,Biotech & Pharma Business,Manufacturing & Supply Chain

    VIVEbiotech expands in vivo lentiviral vector portfolio to 15 programmes

    VIVEbiotech has expanded its in vivo lentiviral vector portfolio to [...]

    June 15, 2026
  • Advanced Therapies,Drug Discovery & Development

    Cartesian licenses WestGene platform to advance in vivo CAR-T for autoimmune diseases

    Cartesian Therapeutics has signed a strategic licensing agreement with WestGene [...]

    June 9, 2026
  • Advanced Therapies,Biotech & Pharma Business,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics

    BBG Advanced Therapies and CELLforCURE partner to provide transatlantic ATMP manufacturing solutions

    BBG Advanced Therapies (BBGAT), a subsidiary of BioBridge Global and [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    CytoAgents receives fourth NIH grant to advance research on cytokine release syndrome in CAR T-cell therapy

    CytoAgents, a clinical-stage biotechnology company developing an oral small-molecule immune [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics

    CTMC and Einstein Hospital Israelita launch global cell therapy alliance

    CTMC, a joint venture between Resilience and MD Anderson Cancer [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    Pheon therapeutics strengthens board with oncology R&D expert Dr Samuel Blackman

    Pheon Therapeutics, a clinical-stage antibody-drug conjugate (ADC) specialist, has appointed [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Opinion & Events,Pharmaceuticals and therapeutics

    Terumo BCT and PwC Belgium join forces to break barriers in access to advanced cell and gene therapies

    Terumo Blood and Cell Technologies (Terumo BCT), a medical technology [...]

    May 5, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Novadip secures €10.4M to advance pivotal Phase 3 trial
    Categories: Advanced Therapies, Biotech & Pharma Business, Clinical & Regulatory, Research & Development, Therapeutic Areas
  • Telix to acquire ITM in $1.65BN radiopharmaceutical deal
    Categories: Biotech & Pharma Business, Manufacturing & Supply Chain, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • Andelyn to manufacture FDA-approved Fayuvi gene therapy for Sanfilippo syndrome
    Categories: Advanced Therapies, Biotech & Pharma Business, Central Nervous System, Clinical & Regulatory, Manufacturing & Supply Chain, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top